151 related articles for article (PubMed ID: 35742646)
1. Trazodone Prolonged-Release Monotherapy in Cannabis Dependent Patients during Lockdown Due to COVID-19 Pandemic: A Case Series.
Mazza M; Caroppo E; Marano G; Kotzalidis GD; Avallone C; Camardese G; Janiri D; Moccia L; Simonetti A; Janiri L; Sani G
Int J Environ Res Public Health; 2022 Jun; 19(12):. PubMed ID: 35742646
[TBL] [Abstract][Full Text] [Related]
2. Substance use during the COVID-19 pandemic: What is really happening?
Mellos E; Paparrigopoulos T
Psychiatriki; 2022 Mar; 33(1):17-20. PubMed ID: 35255473
[TBL] [Abstract][Full Text] [Related]
3. Analyzing the Behavior of Cannabis Users during the COVID-19 Confinement in Spain.
Fernández-Artamendi S; Ruiz MJ; López-Núñez C
Int J Environ Res Public Health; 2021 Oct; 18(21):. PubMed ID: 34769848
[TBL] [Abstract][Full Text] [Related]
4. COVID-19 Lockdown and Consumption Patterns among Substance Use Disorder Outpatients: A Multicentre Study.
Grau-López L; Daigre C; Palma-Alvarez RF; Sorribes-Puertas M; Serrano-Pérez P; Quesada-Franco M; Segura L; Coronado M; Ramos-Quiroga JA; Colom J;
Eur Addict Res; 2022; 28(4):243-254. PubMed ID: 35038702
[TBL] [Abstract][Full Text] [Related]
5. For better or for worse? A pre-post exploration of the impact of the COVID-19 lockdown on cannabis users.
Cousijn J; Kuhns L; Larsen H; Kroon E
Addiction; 2021 Aug; 116(8):2104-2115. PubMed ID: 33394560
[TBL] [Abstract][Full Text] [Related]
6. [Trazodone Contramid® in clinical practice: personalizing antidepressant intervention].
Fagiolini A; Amodeo G; Goracci A; Blardi P
Riv Psichiatr; 2016; 51(4):123-128. PubMed ID: 27727261
[TBL] [Abstract][Full Text] [Related]
7. Profile of patients attending psychiatric emergency care during the coronavirus 2019 (COVID 19) pandemic: a comparative cross-sectional study between lockdown and post-lockdown periods in Lombardy, Italy.
Enrico C; Caldiroli A; Di Brita C; Colmegna F; Nava R; Colzani LC; Sibilla M; Prodi T; Buoli M; Clerici M
Int J Psychiatry Clin Pract; 2022 Jun; 26(2):132-138. PubMed ID: 34151680
[TBL] [Abstract][Full Text] [Related]
8. The efficacy and tolerability of once-daily controlled-release trazodone for depressed mood, anxiety, insomnia, and suicidality in major depressive disorder.
Sheehan DV; Rozova A; Gossen ER; Gibertini M
Psychopharmacol Bull; 2009; 42(4):5-22. PubMed ID: 20581790
[TBL] [Abstract][Full Text] [Related]
9. Selective Changes in Medical Cannabis Use Early in the COVID-19 Pandemic: Findings from a Web-Based Sample of Adults in the United States.
Lake S; Assaf RD; Gorbach PM; Cooper ZD
Cannabis Cannabinoid Res; 2023 Feb; 8(1):174-183. PubMed ID: 35073161
[No Abstract] [Full Text] [Related]
10. Functional Impairment in Response to the COVID-19 Pandemic among Cannabis Users.
Abarno CN; Glover NI; Morris PE; Zvolensky MJ; Buckner JD
Subst Use Misuse; 2021; 56(14):2221-2228. PubMed ID: 34608833
[TBL] [Abstract][Full Text] [Related]
11. Impact of COVID-19 lockdown on individuals under treatment for substance use disorders: Risk factors for adverse mental health outcomes.
Blithikioti C; Nuño L; Paniello B; Gual A; Miquel L
J Psychiatr Res; 2021 Jul; 139():47-53. PubMed ID: 34029833
[TBL] [Abstract][Full Text] [Related]
12. Self-Reported Alcohol, Tobacco, and Cannabis Use during COVID-19 Lockdown Measures: Results from a Web-Based Survey.
Vanderbruggen N; Matthys F; Van Laere S; Zeeuws D; Santermans L; Van den Ameele S; Crunelle CL
Eur Addict Res; 2020; 26(6):309-315. PubMed ID: 32961535
[TBL] [Abstract][Full Text] [Related]
13. [Pharmacological treatment in alcohol-, drug- and benzodiazepine-dependent patients - the significance of trazodone].
Funk S
Neuropsychopharmacol Hung; 2013 Jun; 15(2):85-93. PubMed ID: 23817359
[TBL] [Abstract][Full Text] [Related]
14. Changes in Cannabis Use Risk Behaviors during the First and Second COVID-19 Lockdown in Israel: A Short-term 2-wave Longitudinal Study.
Sznitman SR
J Addict Med; 2022 Nov-Dec 01; 16(6):639-644. PubMed ID: 35165224
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of Cannabis Use Among US Adults During the COVID-19 Pandemic Within Different Legal Frameworks.
Black JC; Amioka E; Iwanicki JL; Dart RC; Monte AA
JAMA Netw Open; 2022 Nov; 5(11):e2240526. PubMed ID: 36342719
[TBL] [Abstract][Full Text] [Related]
16. Cannabis use, abuse and dependence during the COVID-19 pandemic: a scoping review.
Bonnet U; Specka M; Roser P; Scherbaum N
J Neural Transm (Vienna); 2023 Jan; 130(1):7-18. PubMed ID: 36346483
[TBL] [Abstract][Full Text] [Related]
17. Medication and substance use increases among people using cannabis medically during the COVID-19 pandemic.
Boehnke KF; McAfee J; Ackerman JM; Kruger DJ
Int J Drug Policy; 2021 Jun; 92():103053. PubMed ID: 33250438
[TBL] [Abstract][Full Text] [Related]
18. Suicidal ideation among Canadian adults during the COVID-19 pandemic: the role of psychosocial factors and substance use behaviours.
Geda N; Feng C; Peters B
BMC Psychiatry; 2022 Nov; 22(1):711. PubMed ID: 36384538
[TBL] [Abstract][Full Text] [Related]
19. COVID-19 Outcomes: Does the Use of Psychotropic Drugs Make a Difference? Accumulating Evidence of a Beneficial Effect of Antidepressants-A Scoping Review.
Bonnet U; Juckel G
J Clin Psychopharmacol; 2022 May-Jun 01; 42(3):284-292. PubMed ID: 35420565
[TBL] [Abstract][Full Text] [Related]
20. The impact of the COVID-19 Pandemic on the Greek population: Suicidal ideation during the first and second lockdown.
Gournellis R; Efstathiou V
Psychiatriki; 2021 Dec; 32(4):267-270. PubMed ID: 34860683
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
